208 related articles for article (PubMed ID: 1931093)
1. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig.
Thelin S; Bagge L; Hultman J; Borowiec J; Nilsson L; Thorelius J
Eur J Cardiothorac Surg; 1991; 5(9):486-91. PubMed ID: 1931093
[TBL] [Abstract][Full Text] [Related]
2. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
[TBL] [Abstract][Full Text] [Related]
3. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
Bagge L; Borowiec JW; Thelin S; Hultman J
Scand Cardiovasc J; 1997; 31(5):275-81. PubMed ID: 9406294
[TBL] [Abstract][Full Text] [Related]
4. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
Bagge L; Borowiec JW; Thelin S; Hultman J
Scand Cardiovasc J; 1997; 31(6):275-81. PubMed ID: 9498931
[TBL] [Abstract][Full Text] [Related]
5. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
[TBL] [Abstract][Full Text] [Related]
6. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M
Circulation; 1995 Nov; 92(9):2579-84. PubMed ID: 7586360
[TBL] [Abstract][Full Text] [Related]
7. Platelet preservation during cardiopulmonary bypass with iloprost and Duraflo-II heparin-coated surfaces.
Palatianos GM; Dewanjee MK; Smith W; Novak S; Hsu LC; Kapadvanjwala M; Sfakianakis GN; Kaiser GA
ASAIO Trans; 1991; 37(4):620-2. PubMed ID: 1722689
[TBL] [Abstract][Full Text] [Related]
8. Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery--a clinical study.
Borowiec J; Thelin S; Bagge L; van der Linden J; Thörnö E; Hansson HE
Ups J Med Sci; 1992; 97(1):55-66. PubMed ID: 1523735
[TBL] [Abstract][Full Text] [Related]
9. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
Horimoto H; Kondo K; Asada K; Sasaki S
Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
[TBL] [Abstract][Full Text] [Related]
10. Heparin-coated CPB-sets increase biocompatibility and reduce endothelial cell damage in pigs.
Bagge L; Thelin S; Hultman J; Nilsson L; Thorelius J; Hillström PA
J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):84. PubMed ID: 2521017
[No Abstract] [Full Text] [Related]
11. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
Borowiec J; Bagge L; Saldeen T; Thelin S
Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
[TBL] [Abstract][Full Text] [Related]
13. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
[TBL] [Abstract][Full Text] [Related]
14. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
[TBL] [Abstract][Full Text] [Related]
15. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
17. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.
Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476
[TBL] [Abstract][Full Text] [Related]
18. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management.
Weiss BM; von Segesser LK; Turina MI; Seifert B; Pasch T
J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):464-70. PubMed ID: 8776638
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass.
Zhang K; Hu Z; Yang Y; Huang R; Fan H; Sun Z
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):403-6. PubMed ID: 15015647
[TBL] [Abstract][Full Text] [Related]
20. Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study.
Borowiec JW; Bylock A; van der Linden J; Thelin S
Ann Thorac Surg; 1993 Jun; 55(6):1540-5. PubMed ID: 8512409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
